{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T21:59:34Z","timestamp":1769291974317,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Programa Presupuestal P016, Anexo 13 del Decreto del Presupuesto de Egresos de la Federaci\u00f3n"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12357-5","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T03:23:23Z","timestamp":1766028203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in HIV care at a tertiary hospital repurposed for COVID-19: an observational study (2019\u20132022)"],"prefix":"10.1186","volume":"26","author":[{"given":"Karla Alejandra","family":"Romero-Mora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"G\u00f3mez-Palacio-Schjetnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"D\u00e1vila-Conn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Garc\u00eda-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela","family":"Cervantes-Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Alvarado-de","family":"la Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Ehecatl","family":"Schulz-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"\u00c1vila-R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"12357_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/joim.13184","volume":"289","author":"AY Chang","year":"2021","unstructured":"Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review. J Intern Med. 2021;289:450\u201362.","journal-title":"J Intern Med"},{"key":"12357_CR2","unstructured":"World Health Organization. COVID-19 significantly impacts health services for noncommunicable diseases. 2020. Available from: https:\/\/www.who.int\/news\/item\/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases"},{"key":"12357_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/bmb\/ldac031","volume":"147","author":"J Brolly","year":"2023","unstructured":"Brolly J, Chadwick DR. COVID-19 infection in people living with HIV. Br Med Bull. 2023;147:20\u201330.","journal-title":"Br Med Bull"},{"key":"12357_CR4","unstructured":"Global HIV, AIDS statistics - Fact sheet. & 2023. Available from: https:\/\/reliefweb.int\/report\/world\/global-hiv-aids-statistics-fact-sheet-2023?gad_source=1&gclid=Cj0KCQjwn9y1BhC2ARIsAG5IY-6JOPY-4x6YuEnFcQzyQwYHgMYapAqhY1uhCQRbJRw24KTECTu2SIYaAhL8EALw_wcB"},{"key":"12357_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11904-021-00587-6","volume":"19","author":"CW Holtzman","year":"2022","unstructured":"Holtzman CW, Godfrey C, Ismail L, Raizes E, Ake JA, Tefera F, et al. PEPFAR\u2019s role in protecting and leveraging HIV services in the COVID-19 response in Africa. Curr HIV\/AIDS Rep. 2022;19:26\u201336.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"12357_CR6","unstructured":"Gobierno de M\u00e9xico. Secretar\u00eda de Salud. Lineamiento de Reconversi\u00f3n Hospitalaria. Versi\u00f3n 5 de Abril, 2020. Available From: https:\/\/www.Documentos-Lineamientos-Reconversion-Hospitalaria.pdf."},{"key":"12357_CR7","unstructured":"Secretar\u00eda de Gobierno. Diario Oficial de la Federaci\u00f3n. Gu\u00eda de Manejo Antirretroviral de las Personas con VIH. Available from: https:\/\/www.dof.gob.mx\/nota_detalle.php?codigo=5565176%26fecha=08\/07\/2019#gsc.tab=0"},{"key":"12357_CR8","volume-title":"Designing clinical research","author":"SB Hulley","year":"2013","unstructured":"Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Designing clinical research. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.","edition":"4"},{"key":"12357_CR9","doi-asserted-by":"publisher","first-page":"e20200310","DOI":"10.1590\/1983-1447.2021.20200310","volume":"42","author":"CRB Costa","year":"2021","unstructured":"Costa CRB, Melo ES, Antonini M, Silva-Montes P, Gir E, Reis RK, et al. Overweight and obesity in people living with HIV. Rev Gacha Enferm. 2021;42:e20200310.","journal-title":"Rev Gacha Enferm"},{"key":"12357_CR10","unstructured":"Direcci\u00f3n de Vigilancia Epidemiol\u00f3gica de Enfermedades Transmisibles y Direcci\u00f3n de Epidemiolog\u00eda. Sistema de Vigilancia Epidemiol\u00f3gica de VIH. Informe hist\u00f3rico de VIH, 3er trimestre de 2024. Available from: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/960224\/InformeHistorico_VIH_DVEET_3ERTRIMESTRE2024_nuevoformato.pdf"},{"key":"12357_CR11","unstructured":"Centro Nacional para la Prevenci\u00f3n y Control del VIH y el SIDA. Bolet\u00edn D\u00eda Mundial del SIDA 2024. Available from: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/960300\/BOLET_N_DAI_ESPECIAL2024.pdf"},{"key":"12357_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/hiv.13180","volume":"23","author":"F Rick","year":"2022","unstructured":"Rick F, Odoke W, van den Hombergh J, Benzaken AS, Avelino-Silva VI. Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents. HIV Med. 2022;23:169\u201377.","journal-title":"HIV Med"},{"key":"12357_CR13","doi-asserted-by":"publisher","first-page":"e0270831","DOI":"10.1371\/journal.pone.0270831","volume":"17","author":"CC Hung","year":"2022","unstructured":"Hung CC, Banerjee S, Gilada I, Green K, Inoue Y, Kamarulzaman A, et al. Impact of COVID-19 on the HIV care continuum in asia: insights from people living with HIV, key populations, and HIV healthcare providers. PLoS ONE. 2022;17:e0270831.","journal-title":"PLoS ONE"},{"key":"12357_CR14","doi-asserted-by":"publisher","first-page":"e26036","DOI":"10.1002\/jia2.26036","volume":"25","author":"E Brazier","year":"2022","unstructured":"Brazier E, Ajeh R, Maruri F, Musick B, Freeman A, Wester CW, et al. Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc. 2022;25:e26036.","journal-title":"J Int AIDS Soc"},{"key":"12357_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12981-023-00532-0","volume":"20","author":"E Guti\u00e9rrez-Velilla","year":"2023","unstructured":"Guti\u00e9rrez-Velilla E, Barrientos-Casarrubias V, G\u00f3mez-Palacio Schjetnan M, Perrusquia-Ortiz LE, Cruz-Maycott R, Alvarado-de la Barrera C, et al. Mental health and adherence to antiretroviral therapy among Mexican people living with HIV during the COVID-19 pandemic. AIDS Res Ther. 2023;20:34.","journal-title":"AIDS Res Ther"},{"key":"12357_CR16","doi-asserted-by":"publisher","first-page":"e884","DOI":"10.1016\/S2352-3018(22)00268-5","volume":"9","author":"E Murphy","year":"2022","unstructured":"Murphy E, Doherty M, El Sadr W, Zaidi I, Kamarazulman A, Crowley S, et al. Innovations, adaptations, and accelerations in the delivery of HIV services during COVID-19. Lancet HIV. 2022;9:e884\u20136.","journal-title":"Lancet HIV"},{"key":"12357_CR17","doi-asserted-by":"publisher","first-page":"e0003017","DOI":"10.1371\/journal.pgph.0003017","volume":"4","author":"DA Asakitogum","year":"2024","unstructured":"Asakitogum DA, Nutor JJ, Thompson RGA, Alhassan RK, Gyamerah AO. Impact of COVID-19 on people living with HIV and HIV care: A qualitative study in the Volta region of Ghana. PLOS Glob Public Health. 2024;4:e0003017.","journal-title":"PLOS Glob Public Health"},{"key":"12357_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12913-024-10609-9","volume":"24","author":"RM Pinto","year":"2024","unstructured":"Pinto RM, Hall E, Im V, Lee CA, Ethan Park S. Disruptions to HIV services due to the COVID pandemic in the USA: a state-level stakeholder perspective. BMC Health Serv Res. 2024;24:196.","journal-title":"BMC Health Serv Res"},{"key":"12357_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/QAD.0000000000003833","volume":"38","author":"F Mac\u00edas-Gonz\u00e1lez","year":"2024","unstructured":"Mac\u00edas-Gonz\u00e1lez F, Vermandere H, Pi\u00f1eir\u00faa-Menendez A, Bautista-Arredondo S. How the COVID-19 pandemic and the health system\u2019s response reduced HIV testing and increased late diagnoses in Mexico. AIDS. 2024;38:1067\u201372.","journal-title":"AIDS"},{"key":"12357_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/QAI.0000000000003404","volume":"96","author":"J Ben Farhat","year":"2024","unstructured":"Ben Farhat J, Tiendrebeogo T, Malateste K, Poda A, Minga A, Messou E, et al. Effects of the COVID-19 pandemic on ART initiation and access to HIV viral load monitoring in adults living with HIV in West africa: A regression discontinuity analysis. J Acquir Immune Defic Syndr. 2024;96:114\u201320.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"12357_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10461-023-04139-4","volume":"28","author":"W Mude","year":"2024","unstructured":"Mude W, Mwenyango H, Preston R, O\u2019Mullan C, Vaughan G, Jones G. HIV testing disruptions and service adaptations during the COVID-19 pandemic: A systematic literature review. AIDS Behav. 2024;28:186\u2013200.","journal-title":"AIDS Behav"},{"key":"12357_CR22","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/S2352-3018(20)30359-3","volume":"8","author":"J Dorward","year":"2021","unstructured":"Dorward J, Khubone T, Gate K, Ngobese H, Sookrajh Y, Mkhize S, et al. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis. Lancet HIV. 2021;8:e158\u201365.","journal-title":"Lancet HIV"},{"key":"12357_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/s12879-024-09208-0","volume":"24","author":"Y Caro-Vega","year":"2024","unstructured":"Caro-Vega Y, Guerrero-Torres L, C\u00e1rdenas-Ortega A, Martin-Onra\u00ebt A, Rodr\u00edguez-Zulueta P, Romero-Mora K, et al. Characteristics and outcomes of people living with HIV hospitalized at tertiary healthcare institutions during the COVID-19 pandemic in Mexico City. BMC Infect Dis. 2024;24:524.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"12357_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1515\/mr-2024-0013","volume":"4","author":"M Guo","year":"2024","unstructured":"Guo M, Shang S, Li M, Cai G, Li P, Chen X, Li Q. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis\/mechanisms of long COVID. Med Rev (2021). 2024;4(5):367\u201383. https:\/\/doi.org\/10.1515\/mr-2024-0013. PMID: 39444797; PMCID: PMC11495526.","journal-title":"Med Rev (2021)"},{"issue":"1","key":"12357_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1515\/mr-2024-0030","volume":"5","author":"AG Ewing","year":"2024","unstructured":"Ewing AG, Salamon S, Pretorius E, Joffe D, Fox G, Bilodeau S, Bar-Yam Y. Review of organ damage from COVID and long COVID: a disease with a spectrum of pathology. Med Rev (2021). 2024;5(1):66\u201375. https:\/\/doi.org\/10.1515\/mr-2024-0030. PMID: 39974559; PMCID: PMC11834749.","journal-title":"Med Rev (2021)"},{"key":"12357_CR26","unstructured":"World Health Organization. Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022\u20132030: report on progress and gaps 2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240094925"},{"key":"12357_CR27","unstructured":"Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Available at: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv"},{"key":"12357_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1902824","volume":"381","author":"WDF Venter","year":"2019","unstructured":"Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus two different prodrugs of Tenofovir to treat HIV. N Engl J Med. 2019;381:803\u201315.","journal-title":"N Engl J Med"},{"key":"12357_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/03007995.2021.2007006","volume":"38","author":"B Emond","year":"2022","unstructured":"Emond B, Rossi C, C\u00f4t\u00e9-Sergent A, Bookhart B, Anderson D, Lefebvre P, et al. Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir\/cobicistat\/emtricitabine\/tenofovir Alafenamide or bictegravir\/emtricitabine\/tenofovir Alafenamide in the united States. Curr Med Res Opin. 2022;38:287\u201398.","journal-title":"Curr Med Res Opin"},{"key":"12357_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/aid.2022.0130","volume":"39","author":"E P\u00e9rez-Barrag\u00e1n","year":"2023","unstructured":"P\u00e9rez-Barrag\u00e1n E, Guevara-Maldonado MF, Mancilla-Galindo J, Kammar-Garc\u00eda A, Ortiz-Hern\u00e1ndez A, Mata-Mar\u00edn JA, et al. Weight gain after 12 months of switching to Bictegravir\/Emtricitabine\/Tenofovir Alafenamide in virologically suppressed HIV patients. AIDS Res Hum Retroviruses. 2023;39:511\u20137.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"12357_CR31","unstructured":"Coordinaci\u00f3n de Difusi\u00f3n Cultural de la Universidad Nacional Aut\u00f3noma de M\u00e9xico. Encuesta Nacional sobre H\u00e1bitos y Consumo Cultural 2020 [Internet]. Mexico City: UNAM; [cited 2025 Oct 24]. Available from: https:\/\/cultura.unam.mx\/EncuestaConsumoCultural"},{"key":"12357_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAD.0000000000002385","volume":"34","author":"D Sviridov","year":"2020","unstructured":"Sviridov D, Mukhamedova N, Makarov AA, Adzhubei A, Bukrinsky M. Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality. AIDS. 2020;34:1\u201313.","journal-title":"AIDS"},{"key":"12357_CR33","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/S2352-3018(23)00328-4","volume":"11","author":"DM Byonanebye","year":"2024","unstructured":"Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, et al. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, Tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts. Lancet HIV. 2024;11:e321\u201332.","journal-title":"Lancet HIV"},{"key":"12357_CR34","doi-asserted-by":"publisher","first-page":"ofz491","DOI":"10.1093\/ofid\/ofz491","volume":"6","author":"R Galdamez","year":"2019","unstructured":"Galdamez R, Garc\u00eda JA, Fern\u00e1ndez M, Robledano C, Agull\u00f3 V, Garc\u00eda-Abell\u00e1n J, et al. Short-term increase in risk of overweight and concomitant systolic blood pressure elevation in Treatment-Na\u00efve persons starting INSTI-Based antiretroviral therapy. Open Forum Infect Dis. 2019;6:ofz491.","journal-title":"Open Forum Infect Dis"},{"key":"12357_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.21149\/13199","volume":"63","author":"LA Flores-Olivares","year":"2021","unstructured":"Flores-Olivares LA, Cervantes-Hern\u00e1ndez N, Quintana-Mendias E, Enriquez-Del Castillo LA. Actividad f\u00edsica y Estilo de Vida sedentario En adultos, Cambios Durante El Confinamiento Por La pandemia de Covid-19. Salud Publica Mex. 2021;63:825\u20136.","journal-title":"Salud Publica Mex"},{"key":"12357_CR36","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1016\/S2352-3018(20)30241-1","volume":"7","author":"WDF Venter","year":"2020","unstructured":"Venter WDF, Sokhela S, Simmons B, Moorhouse M, Fairlie L, Mashabane N, et al. Dolutegravir with emtricitabine and Tenofovir Alafenamide or Tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and Tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomized, phase 3, non-inferiority trial. Lancet HIV. 2020;7:e666\u201376.","journal-title":"Lancet HIV"},{"key":"12357_CR37","doi-asserted-by":"publisher","first-page":"e471","DOI":"10.1093\/cid\/ciaa177","volume":"71","author":"JE Lake","year":"2020","unstructured":"Lake JE, Wu K, Bares SH, Debroy P, Godfrey C, Koethe JR, et al. Risk factors for weight gain following switch to integrase Inhibitor-Based antiretroviral therapy. Clin Infect Dis. 2020;71:e471\u20137.","journal-title":"Clin Infect Dis"},{"key":"12357_CR38","doi-asserted-by":"publisher","first-page":"e26123","DOI":"10.1002\/jia2.26123","volume":"26","author":"PF Rebeiro","year":"2023","unstructured":"Rebeiro PF, Emond B, Rossi C, Bookhart BK, Shah A, Caron-Lapointe G, et al. Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the united States. J Int AIDS Soc. 2023;26:e26123.","journal-title":"J Int AIDS Soc"},{"key":"12357_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/hiv.12294","volume":"17","author":"AC Achhra","year":"2016","unstructured":"Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, et al. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Med. 2016;17:255\u201368.","journal-title":"HIV Med"},{"issue":"3","key":"12357_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2478\/jtim-2024-0008","volume":"12","author":"S Kang","year":"2024","unstructured":"Kang S, Zheng R. Distribution of the causes of fever of unknown origin in China, 2013\u20132022. J Transl Int Med. 2024;12(3):299\u2013307. https:\/\/doi.org\/10.2478\/jtim-2024-0008. PMID:39081273.","journal-title":"J Transl Int Med"},{"issue":"10","key":"12357_CR41","first-page":"1452","volume":"26","author":"YZ Yin","year":"2006","unstructured":"Yin YZ, Chen XW, Li XM, Hou HY, Shi ZJ. Intrauterine HBV infection: risk factors and impact of HBV DNA. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26(10):1452\u20134. Chinese. PMID:17062350.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"4","key":"12357_CR42","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2478\/jtim-2024-0015","volume":"12","author":"J Wu","year":"2024","unstructured":"Wu J, Wang H, Xiang Z, Jiang C, Xu Y, Zhai G, Ling Z, Chinese Consortium for the Study of Hepatitis E (CCSHE). Role of viral hepatitis in pregnancy and its triggering mechanism. J Transl Int Med. 2024;12(4):344\u201354. https:\/\/doi.org\/10.2478\/jtim-2024-0015. PMID:39360164.","journal-title":"J Transl Int Med"},{"key":"12357_CR43","doi-asserted-by":"publisher","unstructured":"Hudu SA, Shinkafi SH, Jimoh AO. A critical review of diagnostic and prognostic markers of chronic hepatitis B infection. Med Rev (2021). 2024 May 8;4(3):225\u2013234. https:\/\/doi.org\/10.1515\/mr-2024-0022. PMID:38919396.","DOI":"10.1515\/mr-2024-0022"},{"issue":"10","key":"12357_CR44","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s10096-012-1613-y","volume":"31","author":"Y Yang","year":"2012","unstructured":"Yang Y, Deng L, Li X, Shi Z, Chen D, Chen X, Li M, Ma L. Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis. 2012;31(10):2673\u20138. https:\/\/doi.org\/10.1007\/s10096-012-1613-y. Epub 2012 May 9. PMID:22569645.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"12357_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/tropicalmed8020089","volume":"8","author":"KL Chin","year":"2023","unstructured":"Chin KL, Anibarro L, Sarmiento ME, Acosta A. Challenges and the way forward in diagnosis and treatment of tuberculosis infection. Trop Med Infect Disease. 2023;8(2):89. https:\/\/doi.org\/10.3390\/tropicalmed8020089.","journal-title":"Trop Med Infect Disease"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12357-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12357-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12357-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:48:12Z","timestamp":1769168892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12357-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12357"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12357-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Research Ethics Committee and the Research Committee of the INER (Approval No. C53-22). Consent to participate was waived by our Institutional Review Board, it is not applicable. The current research was carried out in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}